Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.089 | 0.003 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |